Postsurgical Evaluation of Secondary Nephrogenic Hyperparathyroidism

Abstract

Parathyroidectomy is useful for the treatment of secondary hyperparathyroidism (SHPT) caused by chronic renal failure. The following three types of parathyroidectomy can be performed: subtotal parathyroidectomy, total parathyroidectomy and total parathyroidectomy plus autologous transplantation (tPTX+AT). Each of the three types of surgery has advantages and disadvantages. The present study retrospectively analyzed the efficacy of tPTX+AT for the treatment of SHPT over 1 year. Thirty-seven patients who were diagnosed with secondary nephrogenic hyperparathyroidism and treated with tPTX+AT were selected between September 2014 and October 2016 and followed up for 1 year. Their average age was 66.5±46.0 years, and the average time of dialysis was 48.1±8.2 months. The patients’ conditions, including the levels of intact parathyroid hormone (iPTH) and bone metabolism, were compared preoperatively and 1 and 7 days and 1, 3, 6 and 12 months after surgery. In addition, the postoperative complications, pathological data, SHPT recurrence and prognosis were examined. The results showed that the postoperative level of ostalgia and cutaneous pruritus significantly decreased in the patients. An inspection of the parathyroid tissues during the operation confirmed the presence of parathyroid gland hyperplasia with no carcinoma detected. Three patients with hoarseness recovered within 1 month, and 1 patient with unilateral recurrent laryngeal nerve injury improved after 6 months of voice training. Compared to the preoperative condition, the postoperative serum iPTH, serum calcium and serum phosphate levels were significantly decreased (P<0.001), and these differences remained significant 12 months after surgery. Compared to the preoperative condition, the alkaline phosphatase (ALP) concentration was decreased on postoperative day 1 (P<0.05), but no differences were observed on day 7 or at 1 month (P>0.05). The ALP levels continuously decreased at 3, 6 and 12 months (P<0.01). In conclusion, tPTX+AT significantly improves the quality of life and serum biomarker levels of these patients. The convenient surgical removal of the hyperplastic parathyroid gland for postoperative recurrence supports tPTX+AT as the recommended treatment for relevant patients.

Keywords

nephrogenic hyperparathyroidism / parathyroidectomy / transplantation / autologous

References

[1] LishmanovA, DorairajanS, PakY, et al.. Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease. Int Urol Nephrol, 2012, 44(2): 541-547

[2] ZouQ, WangHY, ZhouJ, et al.. Total parathyroidectomy combined with partial autotransplantation for the treatment of secondary hyperparathyroidism. Chin Med J (Chinese), 2007, 120(20): 1777-1782

[3] GoodmanWC, GoldinJ, KuizonBD, et al.. Coroar y-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Eng J Med, 2000, 342(20): 1478-1483

[4] FraserWD. Hyperparathyroidism. Lancet, 2009, 374: 145-158

[5] LunL, LiuD, GaoZ, et al.. Effects of parathyroidectomy on quality of life in uremic patients with secondary hyperparthyroidism. Chinese Journal of Blood Purifcation, 2014, 13(1): 23-26

[6] KonturekA, BarczyńskiM, StopaM, et al.. Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study. Langenbecks Arch Surg, 2016, 401(7): 965-974

[7] TominagaY, KatayamaA, SatoT, et al.. Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant, 2003, 18(3): iii65-70

[8] LorenzK, UkkatJ, SekullaC, et al.. Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol. World J Surg, 2006, 30(5): 743-751

[9] SchlosserK, BartschDK, DienerMK, et al.. Total Parathyroidectomy With Routine Thymectomy and Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism: Results of a Nonconfirmatory Multicenter Prospective Randomized Controlled Pilot Trial. Ann Surg, 2016, 264(5): 745-753

[10] LiJG, XiaoZS, HuXJ, et al.. Total parathyroidectomy with forearm auto-transplantation improves the quality of life and reduces the recurrence of secondary hyperparathyroidism in chronic kidney disease patients. Medicine (Baltimore), 2017, 96(49): e9050

[11] LieuD, HirschowitzS L, ShinnerK A, et al.. Recurrent disease after autotransplantation into the sternocleidomastoid muscle. Acta Cytol, 1998, 42: 1195-1198

[12] TolleyN, GarasG, PalazzoF, et al.. Long-term prospective evaluation comparing robotic parathyroidectomy with minimally invasive open parathyroidectomy for primary hyperparathyroidism. Head Neck, 2016, 38(1): E300-E306

[13] SchneiderDF, MazehH, ChenH, et al.. Predictors of recurrence in primary hyperparathyroidism: an analysis of 1386 cases. Ann Surg, 2014, 259(3): 563-568

[14] MohsinK, AlzahraniH, Bu AliD, et al.. Robotic transaxillary parathyroidectomy. Gland Surg, 2017, 6(4): 410-411

[15] LiuQ, GanY, WuJ, et al.. Application of carbon nanoparticles suspension injection in uremic patients with secondary hyperparathyroidism underwent total parathyroidectomy: 2 case report and literature review. J Cent South Univ (Med Sci), 2017, 42(7): 865-868

[16] JayenderJ, LeeT, RuanD. Real-time localization of parathyroid adenoma during parathyroidectomy. N Engl J Med, 2015, 373(1): 96-98

[17] TianY, TannyST, EinsiedelP, et al.. Four-dimensional computed tomography: clinical impact for patients with primary hyperparathyroidism. Ann Surg Oncol, 2018, 25(1): 117-121

[18] RajeevP, LeeKY, TangXJ, et al.. Outcomes of parathyroidectomy in renal hyperparathyroidism in patients with No access to renal transplantation in Singapore. Int J Surg, 2016, 25: 64-68

[19] AndersonK, RuelE, AdamMA, et al.. Subtotal vs. total parathyroidectomy with autotransplantation for patients with renal hyperparathyroidism have similar outcomes. Am J Surg, 2017, 214(5): 914-919

[20] Monier-FaugereMC, GengZ, MawadH, et al.. Improved assessment of bone turnover by the PTH-(1–84)/large C-PTH fragments ratio in ESRD patients. Kidney Int, 2001, 60(4): 1460-1468

[21] LibuttiSK, AlexanderHR, BartlettDL, et al.. Kinetic analysis of the rapid intraoperative parathyroid homone assay in patients during operation for hyperparathyroidism. Surgery, 1999, 126(6): 1145-1150

[22] KimWY, LeeJB, KimH, et al.. Efficacy of intraoperative parathyroid hormone monitoring to predict success of parathyroidectomy for secondary hyperparathyroidism. J Korean Surg Soc, 2012, 83(1): 1-6

[23] ZhengC, ChuP, WuC, et al.. Association between Increased Serum Osteoprotegerin Levels and Improvement in Bone Mineral Density after Parathyroidectomy in Hemodialysis Patients. Tohoku J Exp Med, 2012, 226(1): 19-27

[24] GohBL, YudisthraMG, HishamAN. Alkaline phosphatase predicts calcium requirements after total parathyroidectomy in patients receivingdialysisi. Br J Surg, 2010, 97(2): 185-188

[25] GeP, LiuS, ShengX, et al.. Serum parathyroid hormone and alkaline phosphatase as predictors of calcium requirements after total parathyroidectomy for hypocalcemia in secondary hyperparathyroidism. Head Neck, 2018, 40(2): 324-329

[26] LokeSC, KanesvaranR, YahyaR, et al.. Efficacy of an intravenous calcium gluconate infusion in controlling serum calcium after parathyroidectomy for secondary hyperparathyroidism. Ann Acad Med Singapore, 2009, 38(12): 1074-1080

[27] ZhangJ, GengY, ZhangC. Therapeutic effect of parathyroidectomy for 70 uremic patients with secondary hyperparathyroidism. Chin J Blood Purif, 2014, 9(13): 617-619

[28] TangX, ZhouY, LiK, et al.. Subtotal parathyroidectomy for secondary hyperparathyroidism. J Clin Nephrol, 2011, 11(7): 305-307